The N-terminal region of malaria vaccine candidate <i>Plasmodium falciparum</i> asparagine-rich merozoite antigen is immunodominant and targeted by polyreactive antibodies
Year: 2025
Type: preprint
Language: en
Topic: Malaria Research and Control
Authors and affiliations:
raw_author_name: Rolando Garza
raw_affiliation_strings: Department of Microbiology, Immunology & Molecular Genetics, University of Texas at San Antonio Health Science Center, San Antonio TX, USA
University of Texas at San Antonio Health Science Center
raw_author_name: Jeffrey M. Marchioni
raw_affiliation_strings: Department of Biomedical Engineering, University of Texas at Austin, Austin, TX, USA
University of Texas at Austin
raw_author_name: Jared D. Honeycutt
raw_affiliation_strings: Department of Medicine, University of California San Francisco, San Francisco, CA, USA
University of California San Francisco
raw_author_name: Nicholas K. Hurlburt
raw_affiliation_strings: Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
Fred Hutchinson Cancer Center
raw_author_name: Caroline Torres
raw_affiliation_strings: Department of Microbiology, Immunology & Molecular Genetics, University of Texas at San Antonio Health Science Center, San Antonio TX, USA
University of Texas at San Antonio Health Science Center
raw_author_name: Anakaren Garcia
raw_affiliation_strings: Department of Microbiology, Immunology & Molecular Genetics, University of Texas at San Antonio Health Science Center, San Antonio TX, USA
University of Texas at San Antonio Health Science Center
raw_author_name: Eva Loranc
raw_affiliation_strings: Department of Microbiology, Immunology & Molecular Genetics, University of Texas at San Antonio Health Science Center, San Antonio TX, USA
UTHSCSA
raw_author_name: Emily Yemington
raw_affiliation_strings: Department of Biomedical Engineering, University of Texas at Austin, Austin, TX, USA
University of Texas at Austin
raw_author_name: Dalton Towers
raw_affiliation_strings: Department of Biomedical Engineering, University of Texas at Austin, Austin, TX, USA
University of Texas at Austin
raw_author_name: Isaac Ssewanyana
raw_affiliation_strings: Infectious Disease Research Collaboration, Kampala, Uganda
raw_author_name: Marie Pancera
raw_affiliation_strings: Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
Fred Hutchinson Cancer Center
raw_author_name: Jason J. Lavinder
raw_affiliation_strings: Department of Chemical Engineering, University of Texas at Austin, Austin, TX, USA
University of Texas at Austin
raw_author_name: Prasanna Jagannathan
raw_affiliation_strings: Department of Medicine, Division of Infectious Diseases, Stanford University, Stanford, California, USA
Department of Microbiology & Immunology, Stanford University, Stanford, California, USA
Stanford University
raw_author_name: Bryan Greenhouse
raw_affiliation_strings: Department of Medicine, University of California San Francisco, San Francisco, CA, USA
Chan Zuckerberg Biohub, 499 Illinois St, San Francisco, CA, 9415, USA
EPPIcenter Program, Division of HIV, ID, and Global Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California, USA
raw_author_name: Sebastiaan Bol
raw_affiliation_strings: Department of Microbiology, Immunology & Molecular Genetics, University of Texas at San Antonio Health Science Center, San Antonio TX, USA
University of Texas at San Antonio Health Science Center
raw_author_name: Evelien M. Bunnik
raw_affiliation_strings: Department of Microbiology, Immunology & Molecular Genetics, University of Texas at San Antonio Health Science Center, San Antonio TX, USA
The University of Texas Health Science Center at San Antonio